Tiotropium administered daily for 6 weeks progressively improved endurance time compared with placebo during a constant work rate exercise test (43, 44).
In the attached tendon, the number of non-chondrocytic cells sharply increased at 2 weeks, progressively decreased thereafter but remained higher than controls at all time points.
Mice that were on cuprizone diet for 5 weeks progressively lost myelin as indicated by the loss of MBP immunostaining in the CC.
After one year follow-up, patients receiving ravuconazole at low dose (200 mg/week, 8 weeks) or short dose (400 mg/week, 4 weeks) progressively relapsed, and their parasite levels by qPCR reached values indistinguishable from those receiving placebo.
Fevers developed, and the patient's condition continued to deteriorate for a week, reached a nadir, and progressively improved, despite cessation of albendazole after 3 weeks because of vomiting and abnormal liver function test results.
Briefly, male Wistar rats (3 weeks old, 130 150 g) were subjected to CCl4 inhalation (Merck, Darmstadt, Germany) twice a week for 11 weeks with a progressively increasing exposure time from 1 to 5 minutes.
A 64-year-old female with a history of mild leukopenia was referred with a 1 week history of progressively increasing floaters with 'fogging' of vision and photophobia in the left eye with no changes in the right eye.
The study also provides support for the acceptability of GS in conjunction with a home-based walking program for people with OA, as participants were willing to comply with taking the glucosamine twice daily, wearing a pedometer, completing log sheets, walking three days per week and progressively increasing their steps per 'walking' day.
Calcium deposition started after 1 week and progressively increased to peak at 4 weeks, reaching cumulative levels of deposited calcium at 16 μg per mg scaffold wet weight.
Every day of the week runs progressively later.
